Stock Taper

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF • Roundhill Investments

$33.21 ▼ -1.89% (-0.64)

Managing Company Roundhill Investments

Asset Under Management $56.65M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $20.01

Volume 1,326

Avg Volume 29,442

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

Managing Company Roundhill Investments

Asset Under Management $56.65M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $20.01

Volume 1,326

Avg Volume 29,442

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
LLY	Eli Lilly and Company	16.82%	9.06K	$9.53M
NVO	Novo Nordisk A/S	12.23%	184.94K	$6.93M
PFE	Pfizer Inc.	6.80%	139.25K	$3.85M
VKTX	Viking Therapeutics, Inc.	5.02%	84.07K	$2.84M
AMGN	Amgen Inc.	3.97%	5.80K	$2.25M
AZN	AstraZeneca PLC	3.63%	9.88K	$2.06M
REGN	Regeneron Pharmaceuticals, Inc.	3.08%	2.23K	$1.74M
GPCR	Structure Therapeutics Inc.	2.84%	25.53K	$1.61M
MBX	MBX Biosciences, Inc. Common Stock	1.98%	34.47K	$1.12M
GILD	Gilead Sciences, Inc.	1.86%	7.08K	$1.06M
RYTM	Rhythm Pharmaceuticals, Inc.	1.39%	8.51K	$789.41K
BHVN	Biohaven Ltd.	1.09%	53.41K	$615.32K
WVE	Wave Life Sciences Ltd.	0.81%	32.98K	$459.34K
CRBP	Corbus Pharmaceuticals Holdings, Inc.	0.34%	22.26K	$190.80K

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

42.34%

Denmark

20.48%

China

14.39%

Japan

6.56%

Switzerland

4.78%

South Korea

4.61%

United Kingdom

3.51%

Hong Kong

2.17%

Singapore

0.77%

Other

0.39%

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

42.34%

Denmark

20.48%

China

14.39%

Japan

6.56%

Switzerland

4.78%

South Korea

4.61%

United Kingdom

3.51%

Hong Kong

2.17%

Singapore

0.77%

Other

0.39%

Holdings (Top 20)

LLY

LLY

Eli Lilly and Company

Weight: 16.82% Shares: 9.06K Value: $9.53M

NVO

NVO

Novo Nordisk A/S

Weight: 12.23% Shares: 184.94K Value: $6.93M

PFE

PFE

Pfizer Inc.

Weight: 6.80% Shares: 139.25K Value: $3.85M

VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 5.02% Shares: 84.07K Value: $2.84M

AMGN

AMGN

Amgen Inc.

Weight: 3.97% Shares: 5.80K Value: $2.25M

AZN

AZN

AstraZeneca PLC

Weight: 3.63% Shares: 9.88K Value: $2.06M

REGN

REGN

Regeneron Pharmaceuticals, Inc.

Weight: 3.08% Shares: 2.23K Value: $1.74M

GPCR

GPCR

Structure Therapeutics Inc.

Weight: 2.84% Shares: 25.53K Value: $1.61M

MBX

MBX

MBX Biosciences, Inc. Common Stock

Weight: 1.98% Shares: 34.47K Value: $1.12M

GILD

GILD

Gilead Sciences, Inc.

Weight: 1.86% Shares: 7.08K Value: $1.06M

RYTM

RYTM

Rhythm Pharmaceuticals, Inc.

Weight: 1.39% Shares: 8.51K Value: $789.41K

BHVN

BHVN

Biohaven Ltd.

Weight: 1.09% Shares: 53.41K Value: $615.32K

WVE

WVE

Wave Life Sciences Ltd.

Weight: 0.81% Shares: 32.98K Value: $459.34K

CRBP

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Weight: 0.34% Shares: 22.26K Value: $190.80K